Cue Biopharma

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Cue Biopharma and other ETFs, options, and stocks.

About CUE

Cue Biopharma, Inc. is a clinical-stage biopharmaceutical company, which engages in advancing a portfolio of potentially transformative therapies aimed at enabling functional cures across immunological disorders. Its pipeline includes CUE-221, a novel anti-IgE antibody with a dual mechanism of action, and CUE-401, designed to regulate inflammation and drive Treg-mediated tolerance. 

CEO
Shao Lee Lin
CEOShao Lee Lin
Employees
29
Employees29
Headquarters
Boston, Massachusetts
HeadquartersBoston, Massachusetts
Founded
2014
Founded2014
Employees
29
Employees29

CUE Key Statistics

Market cap
152.48M
Market cap152.48M
Price-Earnings ratio
-0.77
Price-Earnings ratio-0.77
Dividend yield
—
Dividend yield—
Average volume
117.89K
Average volume117.89K
High today
—
High today—
Low today
—
Low today—
Open price
$19.66
Open price$19.66
Volume
229.00
Volume229.00
52 Week high
$45.50
52 Week high$45.50
52 Week low
$4.97
52 Week low$4.97

Stock Snapshot

As of today, Cue Biopharma(CUE) shares are valued at $20.30. The company's market cap stands at 152.48M, with a P/E ratio of -0.77.

During the trading day, Cue Biopharma(CUE) stock saw an opening price of $19.66, a peak of —, and a bottom of —.

Trading activity shows a volume of 229, compared to an average daily volume of 117.89K.

Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $45.50 and a low of $4.97.

Over the past 52 weeks, Cue Biopharma(CUE) stock has traded between a high of $45.50 and a low of $4.97.

People also own

Based on the portfolios of people who own CUE. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.